HNST:NASDAQThe Honest Company, Inc. Analysis
Data as of 2026-05-23 - not real-time
$3.41
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The Honest Company (HNST) is trading at $3.41, comfortably above its 20‑day, 50‑day and 200‑day SMAs (3.37, 3.15 and 3.11 respectively), signaling a short‑term bullish bias despite a modestly neutral RSI of 54.6. The MACD histogram is negative and the signal line is bearish, while volume has been trending down, suggesting some short‑term weakness near the $3.06 support level and a need for confirmation before a breakout toward the $4.05 resistance. Volatility remains high at 65.8% and beta exceeds 1.5**, indicating the stock is more sensitive to market swings and carries elevated price risk.
Fundamentally, the company posted a 19.7% YoY revenue decline to $352 M, yet Q1 FY2026 showed 3.9% organic growth and record gross margins of nearly 40%, reflecting operational improvements highlighted in recent earnings calls. Cash balances of $90 M comfortably cover the $11.8 M debt, and free cash flow of $48 M provides runway, though profitability remains negative with a –5.4% net margin and a –10.8% ROE. The DCF‑derived fair value of $6.40 suggests roughly 19% upside, and analysts (median target $4.00) are upgrading earnings expectations, supporting a “buy” consensus despite the current lack of dividend distribution.
Fundamentally, the company posted a 19.7% YoY revenue decline to $352 M, yet Q1 FY2026 showed 3.9% organic growth and record gross margins of nearly 40%, reflecting operational improvements highlighted in recent earnings calls. Cash balances of $90 M comfortably cover the $11.8 M debt, and free cash flow of $48 M provides runway, though profitability remains negative with a –5.4% net margin and a –10.8% ROE. The DCF‑derived fair value of $6.40 suggests roughly 19% upside, and analysts (median target $4.00) are upgrading earnings expectations, supporting a “buy” consensus despite the current lack of dividend distribution.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near support with bearish MACD signal
- Decreasing volume indicating reduced short‑term momentum
- High volatility and beta increase price risk
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst consensus upgrade and median target $4.00
- Organic revenue growth and record gross margins
- DCF upside of ~19% and strong free cash flow
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Brand positioning in consumer defensive household segment
- Solid cash cushion and manageable debt levels
- Potential to convert margin improvements into sustainable profitability
Key Metrics & Analysis
Financial Health
Revenue Growth-19.70%
Profit Margin-5.39%
P/E Ratio27.1
ROE-10.86%
ROA1.29%
Debt/Equity6.96
P/B Ratio2.3
Op. Cash Flow$23.6M
Free Cash Flow$48.1M
Technical Analysis
TrendBullish
RSI54.6
Support$3.06
Resistance$4.05
MA 20$3.37
MA 50$3.15
MA 200$3.11
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value$6.40
Target Price$4.07
Upside/Downside19.26%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.54
Volatility65.75%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.